Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

BioXcel Corp — BioXcel Therapeutics, Inc. insider: 2 transactions · InsiderLens

Home / Insiders / BioXcel Corp

BioXcel Corp

10% owner at BioXcel Therapeutics, Inc. · on record since Mar 7, 2018

Insider trading activity of BioXcel Corp

Transactions on record: 2; since Mar 18, 2021

Open-market buys: 0

Open-market sells: 1; $14.6M

Companies traded: 1; last filing Jun 29, 2021

Figures computed from official regulatory filings — methodology.

Companies where BioXcel Corp has traded

BioXcel Therapeutics, Inc.2 tx · $24.3M · Jun 29, 2021

Track record of BioXcel Corp

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of BioXcel Corp

Co-insiders of BioXcel Corp

Agarwal AkratiBioXcel Therapeutics, Inc.
Agarwal AneshaBioXcel Therapeutics, Inc.
Agarwal RashmiBioXcel Therapeutics, Inc.
Agarwal VipinBioXcel Therapeutics, Inc.
Aiello Michael JamesBioXcel Therapeutics, Inc.
Balasubramanian SuganthiBioXcel Therapeutics, Inc.
Benabou ReinaBioXcel Therapeutics, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

BioXcel Holdings, Inc.BioXcel Therapeutics, Inc.

Bray JuneBioXcel Therapeutics, Inc.

Gibson Marshal D.BioXcel Therapeutics, Inc.

Gupta Indu R.BioXcel Therapeutics, Inc.

Gupta Tarun K.BioXcel Therapeutics, Inc.

Jain AnitaBioXcel Therapeutics, Inc.

Jain DiwakarBioXcel Therapeutics, Inc.

Kane William P JrBioXcel Therapeutics, Inc.

Laumas SandeepBioXcel Therapeutics, Inc.

MACK DAVID J.BioXcel Therapeutics, Inc.

Mehta VimalBioXcel Therapeutics, Inc.

MILLER MICHAEL PATRICKBioXcel Therapeutics, Inc.

MUELLER PETERBioXcel Therapeutics, Inc.

Nandabalan KrishnanBioXcel Therapeutics, Inc.

O'Neill VincentBioXcel Therapeutics, Inc.

Patel Bina JatinBioXcel Therapeutics, Inc.

Patel Jatin MarkandBioXcel Therapeutics, Inc.

Patel Krunal DilipBioXcel Therapeutics, Inc.

Patni RajivBioXcel Therapeutics, Inc.

Rodriguez JavierBioXcel Therapeutics, Inc.

Sood AlkaBioXcel Therapeutics, Inc.

Sood Pardeep KumarBioXcel Therapeutics, Inc.

Steinhart Richard IBioXcel Therapeutics, Inc.

Votruba MichalBioXcel Therapeutics, Inc.

Wiley Matthew T.BioXcel Therapeutics, Inc.

Yocca FrankBioXcel Therapeutics, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
BioXcel Therapeutics, Inc.	Jun 29, 2021	Sell	-473,250	30.83 USD	$14.6M	SEC
BioXcel Therapeutics, Inc.	Mar 18, 2021	Other	-160,000	60.76 USD	$9.7M	SEC